You can also mix this full-spectrum hemp CBD oil into your favorite beverage. Keep the Bluebird Botanicals CBD oil refrigerated, and shake well before use. While most people find their sweet spot at around 15 drops, your serving size may vary according to your metabolism. Since there are no side-effects and there is no danger of overdosing, you can safely tweak your serving size to find the perfect amount of CBD your body needs. Below you’ll find CBD concentration conversions according to Bluebird Botanicals:
While there is much debate on which form is better, this 2015 study leans in favor of full spectrum CBD oil products. There are many that believe that other cannabinoids, THC especially, are necessary to take full advantage of what cannabis has to offer. Ultimately, however, we are all different and it comes down to the individual user and their needs. If drug testing is a concern, you’re encouraged to seek out CBD isolate products (or terpsolates) or broad spectrum products instead of full spectrum.
Cutting-edge science has shown that the endocannabinoid system is dysregulated in nearly all pathological conditions. Thus, it stands to reason that “modulating endocannabinoid system activity may have therapeutic potential in almost all diseases affecting humans,” as Pal Pacher and George Kunos, scientists with the U.S. National Institutes of Health (NIH), suggested in a 2014 publication.
Agreed. Full Spectrum could legally have .03% or less of THC which will cause you to fail a drug test. That is why I prefer Mezza Luna CBD Broad spectrum. It has 0.0% THC and the test to prove it. Full Disclosure I also work for the company. But I was a client first and the other difference is that there is no plant material in it. It is super clear gold in color and taste just like a light cooking oil. No need to guzzle a bottle of water after it.
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160